Nonalcoholic fatty liver disease as a sentinel marker for the development of diabetes mellitus in non-obese subjects-Reference-Cited by-同舟云学术

Nonalcoholic fatty liver disease as a sentinel marker for the development of diabetes mellitus in non-obese subjects

Published:2018-04 Issue:4 Volume:50 Page:370-377
ISSN:1590-8658
Container-title:Digestive and Liver Disease
language:en
Short-container-title:Digestive and Liver Disease

Author:

Kim Soon Sun^ORCID,Cho Hyo Jung^ORCID,Kim Hyun Ji,Kang Dae Ryong,Berry Jacob R.,Kim Jin Hong,Yang Min Jae,Lim Sun Gyo,Kim SooJin,Cheong Jae Youn,Cho Sung Won

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference65 articles.

1. Controlled attenuation parameter is correlated with actual hepatic fat content in patients with non-alcoholic fatty liver disease with none-to-mild obesity and liver fibrosis;Fujimori;Hepatol Res,2016

2. Significance of hepatic insulin clearance in patients with chronic hepatitis C and non-alcoholic fatty liver disease;Miyaaki;Intern Med,2016

3. Association between nonalcoholic fatty liver disease and carotid intima-media thickness according to the presence of metabolic syndrome;Kim;Atherosclerosis,2009

4. Serum leptin as a predictor of fatty liver in 7-year-old Korean children;Kim;Ann Nutr Metab,2008

5. Nonalcoholic fatty liver disease: a manifestation of the metabolic syndrome;Kim;Cleve Clin J Med,2008

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Global epidemiology of type 2 diabetes in patients with NAFLD or MAFLD: a systematic review and meta-analysis;BMC Medicine;2024-03-06

2. Analyzing and evaluating the prevalence and metabolic profile of lean NAFLD compared to obese NAFLD: a systemic review and meta-analysis;Therapeutic Advances in Endocrinology and Metabolism;2024-01

3. Referral to hepatologists or a second-line examination requirement is common in patients with type 2 diabetes mellitus;Nutrition, Metabolism and Cardiovascular Diseases;2023-12

4. Associations of advanced liver fibrosis with heart failure with preserved ejection fraction in type 2 diabetic patients according to obesity and metabolic goal achievement status;Frontiers in Endocrinology;2023-10-24

5. Longitudinal Outcomes Associated With Metabolic Dysfunction-Associated Steatotic Liver Disease: A Meta-analysis of 129 Studies;Clinical Gastroenterology and Hepatology;2023-09